HTR1E
| Official symbol: | HTR1E |
| Full name: | 5-hydroxytryptamine receptor 1E |
| Location: | 6q14.3 |
| Also known as: | 5-HT1E |
| Entrez ID: | 3354 |
| Ensembl ID: | ENSG00000168830 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | NA |
|
|
|
| |
|
|
|
| Functional class: | G protein-coupled receptor |
| JensenLab PubMed score: | 35.95 (Percentile rank: 57.01%) |
| PubTator score: | 31.27 (Percentile rank: 60.20%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
